Papers
1
Total Citations
25
H-Index
1
About
Kyle Wang is a radiation oncologist whose research focuses on optimizing prostate cancer treatment through stereotactic body radiotherapy (SBRT). His work is particularly concerned with understanding and mitigating the side effects of this precise, high-dose radiation technique. Wang’s major contribution lies in identifying patient-specific and dosimetric factors that predict genitourinary and bowel quality-of-life outcomes following prostate SBRT. His landmark study, a secondary analysis of a multi-institutional trial, is widely cited (25 citations) for providing critical insights that help clinicians tailor treatment plans to minimize toxicity while maintaining cancer control. By linking radiation dose distributions to real-world patient-reported outcomes, Wang has advanced the field’s ability to personalize therapy, reducing the burden of long-term side effects. His research bridges the gap between technical dosimetry and meaningful patient experience, making him a key figure in the movement toward more survivorship-focused prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1